Key facts
- CLINARIS’s last known valuation is $17.5M (Dec 2023).
- It has raised $9.4M; the latest was Later Stage VC ($2.3M) in Apr 2025.
- Notable investors include Tertium Family Office, Kalodion.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for CLINARIS
- ·The full record, as it builds
Funding rounds
No funding rounds for CLINARIS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CLINARIS
Developer of a digital platform designed to improve hospital hygiene. The company's product keeps informed about the location and the technical and hygienic condition of medical products at all times, it controls and documents the legally required reprocessing process of medical devices (beds, mattresses, bedside tables) as well as hospital rooms, enabling hospitals to optimize their bed management processes and take advantage of real-time asset tracking for medical devices.
- Sector
- Healthcare
- HQ
- Munich, Germany
- Founded
- 2014
- Employees
- 16
- Website
- clinaris.com/
- Ownership
- Privately Held (backing)
CLINARIS doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CLINARIS shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CLINARIS in its N-PORT filings yet. We sweep new filings monthly.